Optibrium partners with TalTech on EU-funded PhD program to advance sustainable drug discovery

Nutriție

Optibrium Jul 2 2025 Optibrium, a leading developer of software and AI solutions for molecular design, today announced its partnership with TalTech (Tallinn University of Technology) to co-supervise an EU-funded PhD position as part of the INNOCHEMBIO programme. This research project will focus on developing more accurate metabolism models that will reduce the reliance on costly laboratory experiments while improving speed, efficiency and sustainability in drug discovery. The PhD research will

din zilele anterioare